9 : 49 Hoffenberg EJ, MacKenzie T, Barriga KJ, Eisenbarth GS, Bao F, Haas JE et al
Also ask about less common but more serious risks like pancreatitis, gallbladder problems, vision changes/loss, feelings of depression, and others
Because Tirzepatide is a powerful dual-agonist medication, many patients enrolled in clinical trials achieved results on low doses
WEIGHT MANAGEMENT PROGRAMMES TAKE TIME AND PERSONAL COMMITMENT TO BE EFFECTIVE, AND ALSO REQUIRE DIET, EXERCISE AND LIFESTYLE CHANGES
If tirzepatide becomes hard to source consistently, your provider may transition you to semaglutide to maintain treatment continuity